1. ScholarBank@NUS

Ross Andrew Soo

rp03556

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Ross Andrew Soo
(not current staff)
Variants
Ross, S.
Soo, R.
Soo, R.-A.
Soo, R.A.
Soo, Ross
 
Main Affiliation
 
Faculty
 
Email
csiras@nus.edu.sg
 

Publications

Refined By:
File Format:  Adobe PDF
Author:  Goh, B.C
Policy:  Open

Results 1-20 of 20 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
125-Mar-2020A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaKong, Li Ren ; Salleh, Nur Afiqah Binte Mohamed ; Ong, Richard Weijie; Tan, Tuan Zea ; Syn, Nicholas L; Goh, Robby Miguel; Fhu, Chee Wei ; Tan, Daniel SW ; Iyer, N Gopalakrishna ; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Yaw Chyn ; Soo, Ross ; Ho, Jingshan ; Huang, Yiqing; Lim, Joline SJ ; Yan, Benedict Junrong; Nga, Min En ; Lim, Seng Gee ; Koeffler, H Phillip ; Lee, Soo Chin ; Kappei, Dennis ; Hung, Huynh The ; Goh, Boon Cher 
21-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
315-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
42020A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursAng, Y.L.E.; Ho, G.F.; Soo, R.A. ; Sundar, R. ; Tan, S.H.; Yong, W.P. ; Ow, S.G.W. ; Lim, J.S.J. ; Chong, W.Q.; Soe, P.P.; Tai, B.C. ; Wang, L. ; Goh, B.C. ; Lee, S.-C. 
52016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
616-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
72017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
813-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
92018Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerTsui, D.W.Y; Murtaza, M; Wong, A.S.C ; Rueda, O.M; Smith, C.G; Chandrananda, D; Soo, R.A ; Lim, H.L; Goh, B.C ; Caldas, C; Forshew, T; Gale, D; Liu, W; Morris, J; Marass, F; Eisen, T; Chin, T.M ; Rosenfeld, N
101-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
1114-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
121-Jul-2015MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell CarcinomaKong, Li Ren ; Chua, Kian Ngiap ; Sim, Wen Jing ; Ng, Hsien Chun ; Bi, Chonglei; Ho, Jingshan ; Nga, Min En ; Pang, Yin Huei ; Ong, Weijie Richard; Soo, Ross Andrew ; Huynh, The Hung ; Chng, Wee Joo ; Thiery, Jean-Paul ; Goh, Boon Cher 
132016Pharmacogenetics-Guided Phase i Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursSoo, R.A ; Syn, N; Lee, S.-C; Wang, L; Lim, X.-Y; Loh, M; Tan, S.-H ; Zee, Y.-K; Wong, A.L.-A ; Chuah, B; Chan, D; Lim, S.-E; Goh, B.-C ; Soong, R ; Yong, W.-P 
141-Jun-2022Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patientsHuang, Yiqing; Aminkeng, Folefac ; Wong, Alvin SC; Tay, Sen Hee ; Zhao, Joseph J; Ang, Yvonne; Soo, Ross A ; Goh, Boon Cher 
1523-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
1630-Sep-2022Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang ; Wong, Alvin; Aminkeng, Folefac ; Ang, Yvonne; Asokumaran, Yugarajah; Low, Jia Li; Lee, Matilda; Choo, Joan RE; Chan, Gloria; Kee, Adrian ; Tay, Sen Hee ; Goh, Boon Cher ; Soo, Ross A 
1724-Sep-2021Statistical Process Control Charts for Monitoring Next-Generation Sequencing and Bioinformatics Turnaround in Precision Medicine InitiativesJain, Sneha Rajiv; Sim, Wilson; Ng, Cheng Han; Chin, Yip Han; Lim, Wen Hui; Syn, Nicholas L.; Kamal, Nur Haidah Bte Ahmad; Gupta, Mehek; Heong, Valerie; Lee, Xiao Wen; Sapari, Nur Sabrina ; Koh, Xue Qing; Isa, Zul Fazreen Adam ; Ho, Lucius; O’Hara, Caitlin; Ulagapan, Arvindh; Gu, Shi Yu; Shroff, Kashyap; Weng, Rei Chern; Lim, Joey S. Y.; Lim, Diana ; Pang, Brendan ; Ng, Lai Kuan ; Wong, Andrea ; Soo, Ross Andrew ; Yong, Wei Peng ; Chee, Cheng Ean; Lee, Soo-Chin ; Goh, Boon-Cher ; Soong, Richie ; Tan, David S. P. 
182018Third generation EGFR TKIs: Current data and future directionsTan, C.-S; Kumarakulasinghe, N.B; Huang, Y.-Q; Ang, Y.L.E; Choo, J.R.-E; Goh, B.-C ; Soo, R.A 
192018Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) StudyHeong V.; Syn N.L.; Lee X.W.; Sapari N.S. ; Koh X.Q.; Adam Isa Z.F. ; Sy Lim J.; Lim D. ; Pang B. ; Thian Y.L. ; Ng L.K. ; Wong A.L. ; Soo R.A. ; Yong W.P. ; Chee C.E. ; Lee S.-C., Goh B.-C. ; Soong R. ; Tan D.S.P. 
202020Whole exome sequencing of multi-regional biopsies from metastatic lesions to evaluate actionable truncal mutations using a single-pass percutaneous techniqueHeong V.; Tay D.; Goh S.E. ; Wee B. ; Tan T.Z. ; Soo R. ; Pang B. ; Lim D. ; Gopinathan A. ; Ow S. ; Chee C.E. ; Goh B.C. ; Lee S.C. ; Yong W.P. ; Wong A. ; Omar M.F.M. ; Soong R. ; Tan D.S.P.